ISPOR - Measuring The Impact Of The Food And Drug Administration (Fda) Unapproved Drug Initiative (Udi) On Drug Prices And Expenditures

Full Text

Measuring The Impact Of The Food And Drug Administration (Fda) Unapproved Drug Initiative (Udi) On Drug Prices And Expenditures

Abstract

Authors

D Sharma G Schumock CD Saffore SM Walton

Back to Volume 20, Issue 9

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now